Your browser doesn't support javascript.
loading
Randomized Controlled Trial of the Gastrin/CCK2 Receptor Antagonist Netazepide in Patients with Barrett's Esophagus.
Abrams, Julian A; Del Portillo, Armando; Hills, Caitlin; Compres, Griselda; Friedman, Richard A; Cheng, Bin; Poneros, John; Lightdale, Charles J; De La Rue, Rachel; di Pietro, Massimiliano; Fitzgerald, Rebecca C; Sepulveda, Antonia; Wang, Timothy C.
Afiliación
  • Abrams JA; Department of Medicine, Columbia University Irving Medical Center, New York, New York. ja660@cumc.columbia.edu.
  • Del Portillo A; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York.
  • Hills C; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York.
  • Compres G; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York.
  • Friedman RA; Department of Medicine, Columbia University Irving Medical Center, New York, New York.
  • Cheng B; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York.
  • Poneros J; Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York.
  • Lightdale CJ; Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, New York.
  • De La Rue R; Department of Medicine, Columbia University Irving Medical Center, New York, New York.
  • di Pietro M; Department of Medicine, Columbia University Irving Medical Center, New York, New York.
  • Fitzgerald RC; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York.
  • Sepulveda A; MRC Cancer Unit, Hutchison-MRC Research Centre, University of Cambridge, Cambridge, United Kingdom.
  • Wang TC; MRC Cancer Unit, Hutchison-MRC Research Centre, University of Cambridge, Cambridge, United Kingdom.
Cancer Prev Res (Phila) ; 14(6): 675-682, 2021 06.
Article en En | MEDLINE | ID: mdl-33782049
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Compuestos de Fenilurea / Esófago de Barrett / Benzodiazepinonas / Neoplasias Esofágicas / Adenocarcinoma Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Prev Res (Phila) Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Compuestos de Fenilurea / Esófago de Barrett / Benzodiazepinonas / Neoplasias Esofágicas / Adenocarcinoma Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Prev Res (Phila) Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article